55 related articles for article (PubMed ID: 12508917)
1. The nutritional status has no major role in the age-related reduction of IGF-I secretion.
Baffoni C; Benso A; Broglio F; Tassone F; Bellone S; Corneli G; Rovere S; Origlia C; Aimaretti G
J Endocrinol Invest; 2002; 25(10 Suppl):53-4. PubMed ID: 12508917
[No Abstract] [Full Text] [Related]
2. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
Benso A; Broglio F; Gottero C; Di Vito L; Arvat E; Bobbio M; Ghigo E
J Endocrinol Invest; 1999; 22(10 Suppl):63. PubMed ID: 10727049
[No Abstract] [Full Text] [Related]
3. Correlation between the components of the insulin-like growth factor I system, nutritional status and visceral leishmaniasis.
Gomes CM; Giannella-Neto D; Gama ME; Pereira JC; Campos MB; Corbett CE
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):660-7. PubMed ID: 17442352
[TBL] [Abstract][Full Text] [Related]
4. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
6. [Neuroregulation of GH secretion in aging].
Arvat E; Gianotti L; Goffi S; Maccario M; Bellone J; Procopio M; Camanni F; Ghigo E
Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):14-20. PubMed ID: 7910654
[No Abstract] [Full Text] [Related]
7. The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.
Blazejewski S; Georges A; Forest K; Corcuff JB; Abouelfath A; Girodet PO; Kamagate M; Jacquet A; Pillet O; Bordenave L; Moore N
Fundam Clin Pharmacol; 2009 Jun; 23(3):339-44. PubMed ID: 19527301
[TBL] [Abstract][Full Text] [Related]
8. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men.
Giovannucci E; Pollak M; Liu Y; Platz EA; Majeed N; Rimm EB; Willett WC
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):84-9. PubMed ID: 12582016
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
10. IGF-I levels in obesity: their relationship to blood pressure levels.
Dall'Aglio E; Maggio M; Benedetti N; Caporotundo S; Salimbeni I; Banchini A; Strata A; Valenti G; Ceda GP
J Endocrinol Invest; 1999; 22(10 Suppl):49-50. PubMed ID: 10727042
[No Abstract] [Full Text] [Related]
11. Hormone replacement for disabilities and diseases of aging.
Dwivedi RN
J Indian Med Assoc; 1998 May; 96(5):139-40. PubMed ID: 9828566
[No Abstract] [Full Text] [Related]
12. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.
Fischer F; Schulte H; Mohan S; Tataru MC; Köhler E; Assmann G; von Eckardstein A
Clin Endocrinol (Oxf); 2004 Nov; 61(5):595-602. PubMed ID: 15521962
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
15. [Are age and educational level the determinants of hormonal parameters considered as indices of andropause?].
Jankowska EA; Szklarska A; Lopuszańska M; Medraś M
Pol Merkur Lekarski; 2004 Apr; 16(94):323-7. PubMed ID: 15517925
[TBL] [Abstract][Full Text] [Related]
16. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children.
Gunnell D; Miller LL; Rogers I; Holly JM;
Pediatrics; 2005 Nov; 116(5):e681-6. PubMed ID: 16263982
[TBL] [Abstract][Full Text] [Related]
17. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).
Friedrich N; Alte D; Völzke H; Spilcke-Liss E; Lüdemann J; Lerch MM; Kohlmann T; Nauck M; Wallaschofski H
Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337
[TBL] [Abstract][Full Text] [Related]
18. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
Axelsson J; Qureshi AR; Divino-Filho JC; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P
Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
[TBL] [Abstract][Full Text] [Related]
19. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
Szereday Z; Schally AV; Varga JL; Kanashiro CA; Hebert F; Armatis P; Groot K; Szepeshazi K; Halmos G; Busto R
Cancer Res; 2003 Nov; 63(22):7913-9. PubMed ID: 14633721
[TBL] [Abstract][Full Text] [Related]
20. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
Darzy KH; Thorner MO; Shalet SM
Clin Endocrinol (Oxf); 2009 Feb; 70(2):287-93. PubMed ID: 18673465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
